Atea Pharmaceuticals shares owned by Barclays
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $700k | 242k | 2.90 |
| 2025-06-30 | $941k | 262k | 3.59 |
| 2025-03-31 | $512k | 171k | 2.99 |
| 2024-12-31 | $671k | 200k | 3.35 |
| 2024-09-30 | $593k | 177k | 3.35 |
| 2024-06-30 | $336k | 102k | 3.31 |
| 2024-03-31 | $588k | 146k | 4.04 |
| 2023-12-31 | $601k | 197k | 3.05 |
| 2023-09-30 | $77k | 26k | 3.01 |
| 2023-06-30 | $57k | 15k | 3.73 |
| 2023-03-31 | $131k | 39k | 3.37 |
| 2022-12-31 | $126k | 26k | 4.83 |
| 2022-09-30 | $211k | 37k | 5.70 |
| 2022-06-30 | $333k | 47k | 7.09 |
| 2022-03-31 | $449k | 62k | 7.23 |